11.2 Capital Investor

11.2 Capital
Technology:
Drug Discovery
Headquarters:
San Francisco, California, United States
Acquisitions Number:
7
Funding Status:
Undisclosed
Investment Stage:
Early Stage Venture, Seed
Founded Date:
2014
Number Of Exists:
11
Investors Number:
45
Zip:
NA
Employee Number:
2022-10-01 00:00:00
Industry:
Finance & Banking
Investor Type:
Technology - oriented Investor with Venture Investment Focus